Enzo Biochem, Inc. (ENZ)
USD 0.31
(-17.77%)
USD 0.31
(-17.77%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -9.81 Million USD | 60.31% |
| 2023 | -24.73 Million USD | -59.52% |
| 2022 | -15.5 Million USD | -256.99% |
| 2021 | 9.87 Million USD | 141.79% |
| 2020 | -23.63 Million USD | -130.25% |
| 2019 | 78.13 Million USD | 742.34% |
| 2018 | -12.16 Million USD | -296.74% |
| 2017 | -3.06 Million USD | -106.52% |
| 2016 | 47 Million USD | 3997.43% |
| 2015 | -1.2 Million USD | 88.15% |
| 2014 | -10.18 Million USD | 46.36% |
| 2013 | -18.98 Million USD | 53.11% |
| 2012 | -40.47 Million USD | -213.11% |
| 2011 | -12.92 Million USD | 41.39% |
| 2010 | -22.05 Million USD | 8.31% |
| 2009 | -24.05 Million USD | -62.71% |
| 2008 | -14.78 Million USD | 29.48% |
| 2007 | -20.96 Million USD | -4.03% |
| 2006 | -20.15 Million USD | -95.55% |
| 2005 | -10.3 Million USD | 15.75% |
| 2004 | -12.23 Million USD | -379.88% |
| 2003 | 4.37 Million USD | -51.38% |
| 2002 | 8.98 Million USD | -2.59% |
| 2001 | 9.22 Million USD | 81.52% |
| 2000 | 5.08 Million USD | 54.05% |
| 1999 | 3.3 Million USD | 312.5% |
| 1998 | 800 Thousand USD | 366.67% |
| 1997 | -300 Thousand USD | 80.0% |
| 1996 | -1.5 Million USD | 11.76% |
| 1995 | -1.7 Million USD | -325.0% |
| 1994 | -400 Thousand USD | 92.16% |
| 1993 | -5.1 Million USD | -828.57% |
| 1992 | 700 Thousand USD | 126.92% |
| 1991 | -2.6 Million USD | -23.81% |
| 1990 | -2.1 Million USD | 47.5% |
| 1989 | -4 Million USD | -37.93% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -1.42 Million USD | 74.0% |
| 2024 Q4 | -2.66 Million USD | -97.26% |
| 2024 Q1 | -5.47 Million USD | -139.68% |
| 2024 Q3 | -1.35 Million USD | 5.13% |
| 2023 FY | -24.73 Million USD | -59.52% |
| 2023 Q4 | 13.8 Million USD | 221.5% |
| 2023 Q1 | -8.84 Million USD | 34.39% |
| 2023 Q2 | -11.98 Million USD | -35.53% |
| 2023 Q3 | -11.35 Million USD | 5.22% |
| 2022 Q1 | -1.83 Million USD | 48.86% |
| 2022 FY | -15.5 Million USD | -256.99% |
| 2022 Q4 | -13.47 Million USD | -2102.12% |
| 2022 Q3 | -612 Thousand USD | 68.17% |
| 2022 Q2 | -1.92 Million USD | -4.97% |
| 2021 FY | 9.87 Million USD | 141.79% |
| 2021 Q3 | 2.06 Million USD | 20.88% |
| 2021 Q4 | -3.58 Million USD | -273.29% |
| 2021 Q1 | 497 Thousand USD | 111.22% |
| 2021 Q2 | 1.71 Million USD | 244.06% |
| 2020 FY | -23.63 Million USD | -130.25% |
| 2020 Q1 | -8.2 Million USD | -44.8% |
| 2020 Q4 | -4.43 Million USD | 54.43% |
| 2020 Q2 | -8 Million USD | 2.36% |
| 2020 Q3 | -9.72 Million USD | -21.41% |
| 2019 Q3 | 22.26 Million USD | 350.41% |
| 2019 Q1 | -5.97 Million USD | -4.66% |
| 2019 Q4 | -5.66 Million USD | -125.44% |
| 2019 Q2 | -8.89 Million USD | -48.76% |
| 2019 FY | 78.13 Million USD | 742.34% |
| 2018 Q3 | -2.79 Million USD | 7.23% |
| 2018 Q2 | -3.01 Million USD | -372.73% |
| 2018 Q1 | -638 Thousand USD | -11.54% |
| 2018 FY | -12.16 Million USD | -296.74% |
| 2018 Q4 | -5.71 Million USD | -104.15% |
| 2017 Q4 | -572 Thousand USD | -151.98% |
| 2017 Q3 | -227 Thousand USD | 77.5% |
| 2017 FY | -3.06 Million USD | -106.52% |
| 2017 Q2 | -1 Million USD | 19.79% |
| 2017 Q1 | -1.25 Million USD | -103.36% |
| 2016 Q4 | 37.42 Million USD | 1588.54% |
| 2016 Q1 | 4.63 Million USD | -46.11% |
| 2016 Q3 | -2.51 Million USD | -133.71% |
| 2016 FY | 47 Million USD | 3997.43% |
| 2016 Q2 | 7.45 Million USD | 60.84% |
| 2015 Q4 | 8.6 Million USD | 402.35% |
| 2015 Q2 | -3.88 Million USD | -25.84% |
| 2015 FY | -1.2 Million USD | 88.15% |
| 2015 Q1 | -3.08 Million USD | -1.02% |
| 2015 Q3 | -2.84 Million USD | 26.67% |
| 2014 FY | -10.18 Million USD | 46.36% |
| 2014 Q1 | -3.02 Million USD | 10.91% |
| 2014 Q2 | -3.55 Million USD | -17.65% |
| 2014 Q3 | -555 Thousand USD | 84.38% |
| 2014 Q4 | -3.05 Million USD | -450.09% |
| 2013 FY | -18.98 Million USD | 53.11% |
| 2013 Q4 | -3.39 Million USD | 39.56% |
| 2013 Q3 | -5.6 Million USD | 6.42% |
| 2013 Q2 | -5.99 Million USD | -50.45% |
| 2013 Q1 | -3.98 Million USD | 86.16% |
| 2012 FY | -40.47 Million USD | -213.11% |
| 2012 Q4 | -28.78 Million USD | -717.35% |
| 2012 Q3 | -3.52 Million USD | 7.39% |
| 2012 Q2 | -3.8 Million USD | 12.82% |
| 2012 Q1 | -4.36 Million USD | -8.64% |
| 2011 Q4 | -4.01 Million USD | -77.18% |
| 2011 FY | -12.92 Million USD | 41.39% |
| 2011 Q3 | -2.26 Million USD | 59.27% |
| 2011 Q2 | -5.56 Million USD | -411.87% |
| 2011 Q1 | -1.08 Million USD | 81.53% |
| 2010 Q4 | -5.88 Million USD | -37.97% |
| 2010 Q3 | -4.26 Million USD | 57.51% |
| 2010 FY | -22.05 Million USD | 8.31% |
| 2010 Q2 | -10.04 Million USD | -438.97% |
| 2010 Q1 | -1.86 Million USD | 65.9% |
| 2009 FY | -24.05 Million USD | -62.71% |
| 2009 Q2 | -7.56 Million USD | -22.19% |
| 2009 Q3 | -4.22 Million USD | 44.15% |
| 2009 Q4 | -5.46 Million USD | -29.29% |
| 2009 Q1 | -6.19 Million USD | -53.25% |
| 2008 Q2 | -5.19 Million USD | -83.45% |
| 2008 Q4 | -4.04 Million USD | -48.89% |
| 2008 FY | -14.78 Million USD | 29.48% |
| 2008 Q1 | -2.83 Million USD | 42.29% |
| 2008 Q3 | -2.71 Million USD | 47.78% |
| 2007 FY | -20.96 Million USD | -4.03% |
| 2007 Q4 | -4.9 Million USD | 7.41% |
| 2007 Q3 | -5.3 Million USD | 29.8% |
| 2007 Q2 | -7.55 Million USD | -83.68% |
| 2007 Q1 | -4.11 Million USD | 29.98% |
| 2006 FY | -20.15 Million USD | -95.55% |
| 2006 Q4 | -5.87 Million USD | -26.79% |
| 2006 Q3 | -4.63 Million USD | 19.83% |
| 2006 Q2 | -5.77 Million USD | -49.3% |
| 2006 Q1 | -3.87 Million USD | 1.42% |
| 2005 Q1 | -2.15 Million USD | 68.59% |
| 2005 FY | -10.3 Million USD | 15.75% |
| 2005 Q4 | -3.92 Million USD | -32.22% |
| 2005 Q3 | -2.96 Million USD | -136.95% |
| 2005 Q2 | -1.25 Million USD | 41.91% |
| 2004 Q3 | -1.19 Million USD | 60.95% |
| 2004 Q1 | -1.1 Million USD | 78.0% |
| 2004 FY | -12.23 Million USD | -379.88% |
| 2004 Q4 | -6.86 Million USD | -473.64% |
| 2004 Q2 | -3.06 Million USD | -178.13% |
| 2003 Q3 | 1.62 Million USD | -18.47% |
| 2003 Q2 | 1.99 Million USD | -65.43% |
| 2003 Q1 | 5.76 Million USD | 334.45% |
| 2003 Q4 | -5 Million USD | -408.42% |
| 2003 FY | 4.37 Million USD | -51.38% |
| 2002 FY | 8.98 Million USD | -2.59% |
| 2002 Q1 | 2.64 Million USD | 4.91% |
| 2002 Q2 | 979 Thousand USD | -62.97% |
| 2002 Q3 | 4.04 Million USD | 312.67% |
| 2002 Q4 | 1.32 Million USD | -67.17% |
| 2001 Q1 | 2.13 Million USD | 28.0% |
| 2001 Q2 | 1.93 Million USD | -9.22% |
| 2001 Q3 | 2.63 Million USD | 35.79% |
| 2001 Q4 | 2.52 Million USD | -4.28% |
| 2001 FY | 9.22 Million USD | 81.52% |
| 2000 Q3 | 1.39 Million USD | 39.8% |
| 2000 FY | 5.08 Million USD | 54.05% |
| 2000 Q1 | 1 Million USD | 11.11% |
| 2000 Q2 | 1 Million USD | 0.0% |
| 2000 Q4 | 1.66 Million USD | 19.37% |
| 1999 Q4 | 900 Thousand USD | -18.18% |
| 1999 Q1 | 200 Thousand USD | 100.0% |
| 1999 FY | 3.3 Million USD | 312.5% |
| 1999 Q2 | 900 Thousand USD | 350.0% |
| 1999 Q3 | 1.1 Million USD | 22.22% |
| 1998 Q1 | 100 Thousand USD | -66.67% |
| 1998 Q2 | 200 Thousand USD | 100.0% |
| 1998 FY | 800 Thousand USD | 366.67% |
| 1998 Q4 | 100 Thousand USD | -75.0% |
| 1998 Q3 | 400 Thousand USD | 100.0% |
| 1997 Q4 | 300 Thousand USD | 200.0% |
| 1997 Q1 | -300 Thousand USD | 94.64% |
| 1997 Q2 | -400 Thousand USD | -33.33% |
| 1997 FY | -300 Thousand USD | 80.0% |
| 1997 Q3 | 100 Thousand USD | 125.0% |
| 1996 Q1 | 1 Million USD | 138.46% |
| 1996 Q4 | -5.6 Million USD | -500.0% |
| 1996 Q3 | 1.4 Million USD | 250.0% |
| 1996 Q2 | 400 Thousand USD | -60.0% |
| 1996 FY | -1.5 Million USD | 11.76% |
| 1995 Q4 | -2.6 Million USD | -2500.0% |
| 1995 Q2 | 800 Thousand USD | 14.29% |
| 1995 FY | -1.7 Million USD | -325.0% |
| 1995 Q1 | 700 Thousand USD | 450.0% |
| 1995 Q3 | -100 Thousand USD | -112.5% |
| 1994 Q4 | -200 Thousand USD | 0.0% |
| 1994 Q3 | -200 Thousand USD | 60.0% |
| 1994 FY | -400 Thousand USD | 92.16% |
| 1994 Q1 | 400 Thousand USD | 107.02% |
| 1994 Q2 | -500 Thousand USD | -225.0% |
| 1993 Q3 | - USD | -100.0% |
| 1993 Q4 | -5.7 Million USD | 0.0% |
| 1993 Q2 | 200 Thousand USD | -50.0% |
| 1993 Q1 | 400 Thousand USD | 233.33% |
| 1993 FY | -5.1 Million USD | -828.57% |
| 1992 Q1 | 400 Thousand USD | 100.0% |
| 1992 Q4 | -300 Thousand USD | -250.0% |
| 1992 FY | 700 Thousand USD | 126.92% |
| 1992 Q3 | 200 Thousand USD | -50.0% |
| 1992 Q2 | 400 Thousand USD | 0.0% |
| 1991 Q1 | -600 Thousand USD | -250.0% |
| 1991 FY | -2.6 Million USD | -23.81% |
| 1991 Q2 | -1.2 Million USD | -100.0% |
| 1991 Q4 | 200 Thousand USD | 118.18% |
| 1991 Q3 | -1.1 Million USD | 8.33% |
| 1990 Q1 | -300 Thousand USD | 97.22% |
| 1990 Q4 | 400 Thousand USD | 140.0% |
| 1990 FY | -2.1 Million USD | 47.5% |
| 1990 Q2 | -1.2 Million USD | -300.0% |
| 1990 Q3 | -1 Million USD | 16.67% |
| 1989 FY | -4 Million USD | -37.93% |
| 1989 Q1 | 2.2 Million USD | 122.92% |
| 1989 Q3 | 2.4 Million USD | 9.09% |
| 1989 Q4 | -10.8 Million USD | -550.0% |
| 1989 Q2 | 2.2 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Agilent Technologies, Inc. | 1.35 Billion USD | 100.727% |
| Charles River Laboratories International, Inc. | 617.26 Million USD | 101.59% |
| Quest Diagnostics Incorporated | 1.26 Billion USD | 100.778% |
| Danaher Corporation | 5.2 Billion USD | 100.189% |
| IQVIA Holdings Inc. | 1.97 Billion USD | 100.497% |
| Laboratory Corporation of America Holdings | 725.6 Million USD | 101.353% |
| Mettler-Toledo International Inc. | 1.15 Billion USD | 100.852% |
| Qiagen N.V. | 445.24 Million USD | 102.205% |
| Revvity, Inc. | 300.56 Million USD | 103.266% |
| Thermo Fisher Scientific Inc. | 6.85 Billion USD | 100.143% |
| Waters Corporation | 817.67 Million USD | 101.201% |